Gayer Charles K bought BCRX
May 13, 2024 · Form 4 insider transaction
Gayer Charles K bought 30,000 shares of BioCryst Pharmaceuticals, Inc. at $5.47 per share, a transaction worth $164.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$5.47
Total value
$164.1K
InsiderGayer Charles K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 13, 2024
Filing dateMay 15, 2024
Shares owned after307,533
OwnershipDirect
10b5-1 planNo
AmendedNo